usd

Latest stories

  • in Health care

    The Maximon Longevity Prize 2023: 50,000 CHF (56,000 USD)

    by

    Maximon, Europe’s first longevity company builder, is pleased to announce that applications for the Maximon Longevity Prize 2023 are now open. This prestigious prize is awarded to translational longevity research projects that demonstrate exceptional potential to extend human healthspan and lifespan. Maximon rewards the three winners of the prize with 50,000 CHF (56,000 USD). In […] More

  • in Health care

    GSK plans to acquire Bellus Health for USD 2 billion

    by

    London: GSK plans to buy Canada-based drug developer Bellus Health Inc in an all-cash deal for $2 billion as the British drugmaker expands its bet on respiratory therapies. The move to replenish its pipeline comes as GSK investors fret about whether there is enough in the medicine cabinet to keep the momentum going into the next […] More

  • 17 Views

    in Health care

    Eli Lilly to invest additional USD 1.6 billion in 2 new plants

    by

    Indianapolis: Eli Lilly and Company has announced that it will invest an additional $1.6 billion and add another 200 new jobs at its two new manufacturing sites within LEAP Innovation Park in Boone County, bringing the company’s total commitment to $3.7 billion and up to 700 new jobs. The company also committed $15 million over five years […] More

  • in Health care

    Merck to acquire Prometheus Biosciences for USD 11 billion

    by

    Rahway: Merck, known as MSD outside the United States and Canada, and Prometheus Biosciences, Inc. have announced that the companies have entered into a definitive agreement under which Merck, through a subsidiary, has agreed to acquire Prometheus for $200.00 per share in cash for a total equity value of approximately $10.8 billion. “At Merck, we […] More

  • in Health care

    Johnson & Johnson proposes USD 8.9 billion settlement for talc cancer claims

    by

    US pharmaceutical giant Johnson & Johnson on Tuesday proposed an $8.9 billion settlement to resolve years-old lawsuits claiming that its talcum powder products caused cancer. The New Jersey-based company said the proposed settlement, which still needs the approval of a bankruptcy court, “will equitably and efficiently resolve all claims arising from cosmetic talc litigation.” For […] More

  • in Health care

    JnJ proposes USD 8.9 billion settlement of talc cancer claims

    by

    US: US pharmaceutical giant Johnson & Johnson on Tuesday proposed an $8.9 billion settlement to resolve years-old lawsuits claiming that its talcum powder products caused cancer. The New Jersey-based company said the proposed settlement, which still needs the approval of a bankruptcy court, “will equitably and efficiently resolve all claims arising from cosmetic talc litigation.” […] More